BioLife Solutions, Inc.
BLFS
$25.65
-$0.26-1.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 89.82% | 118.98% | 100.93% | 70.79% | 25.83% |
| Total Depreciation and Amortization | 13.99% | -29.56% | -23.21% | -75.75% | -70.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -100.00% | -100.00% |
| Total Other Non-Cash Items | -51.02% | -100.55% | -97.15% | -68.40% | -33.06% |
| Change in Net Operating Assets | -678.54% | -690.70% | -207.86% | -20.07% | -80.51% |
| Cash from Operations | 18,602.38% | 202.61% | 167.46% | 230.85% | 92.20% |
| Capital Expenditure | 16.44% | 50.46% | 65.08% | 61.70% | 59.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -9.75% | 332.36% | 325.07% | 223.83% | 179.14% |
| Cash from Investing | 165.29% | 113.38% | 226.85% | -1,022.29% | 56.69% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2,206.42% | -1,688.82% | -1,629.27% | -363.21% | 76.37% |
| Issuance of Common Stock | -98.76% | -98.94% | -98.95% | 4,986.34% | 7,005.44% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 103.01% | 188.17% | 160.83% | 202.69% | 75.25% |
| Cash from Financing | -225.07% | -186.49% | -164.04% | 5,615.20% | -48.06% |
| Foreign Exchange rate Adjustments | 212.07% | 212.07% | -100.00% | 47.83% | -162.37% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,505.37% | 251.50% | 275.50% | 162.75% | 123.63% |